Ablation clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
open to eligible people ages 18-100
This is a prospective, non-randomized, multi-center, real-world post-market study to collect and evaluate data regarding the performance of the enhanced atrial fibrillation detection algorithm of the Assert-IQTM Implantable Cardiac Monitor (ICM) device.
at UCSD
Our lead scientists for Ablation research studies include Ulrika Birgersdotter-Green.
Last updated: